The Chicago freight broker Echo Global Logistics Inc. has agreed to acquire ITS Logistics, a third-party logistics provider (3PL) based in Reno, Nevada, saying the combined companies will become a transportation and logistics platform with revenue of $5.4 billion.Founded in 1999, ITS Logistics...
A new malicious package discovered in the Python Package Index (PyPI) has been found to impersonate a popular library for symbolic mathematics to deploy malicious payloads, including a cryptocurrency miner, on Linux hosts. The package, named sympy-dev, mimics SymPy, replicating the...
Security teams at agile, fast-growing companies often have the same mandate: secure the business without slowing it down. Most teams inherit a tech stack optimized for breakneck growth, not resilience. In these environments, the security team is the helpdesk, the compliance expert, and the...
Most of this week’s threats didn’t rely on new tricks. They relied on familiar systems behaving exactly as designed, just in the wrong hands. Ordinary files, routine services, and trusted workflows were enough to open doors without forcing them. What stands out is how little friction attackers...
A step forward in our understanding of how plants produce alkaloids could herald new pharmaceuticals. Biologists from the University of York (UK) have discovered enzymes that catalyze the biosynthesis of alkaloids in a number of plant species. In doing so, they have identified a surprising...
AI is transforming how scientists mine biology for therapeutics, allowing researchers to dive deeper into both human and ancient biology to look for novel therapeutic molecules. We spoke with César de la Fuente (left) – Presidential Associate Professor at the University of Pennsylvania (PA, USA)...
Original story from Elsevier (Amsterdam, Netherlands). New Bridge Capture method offers advances for clinical testing, disease monitoring and treatment selection. A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of...
Long-term data suggest Moderna’s personalized melanoma shot provides “durable tumor control,” one analyst said. Elsewhere, Insilico Medicine partnered with a startup on a popular drug target.
Continue reading →